Tag
BioMarin Pharmaceutical Inc
2 articles
BioMarin Q1 2026 Beats Forecasts, Stock Slides 1.5%
BioMarin posted Q1 2026 EPS $0.76 vs $0.74 forecast and revenue $766 million vs $755.94 million expected.
Despite the beat, shares fell 1.52% in after‑hours trading, closing at $53.24.
Updated full‑ye
BioMarin Q1 2026 EPS Beats, Stock -1.5%
BioMarin reported Q1 2026 EPS of $0.76 versus $0.74 forecast and revenue $766 million versus $755.94 million expected.
Despite beating forecasts, after‑hours stock fell 1.52% to $53.24, trading near i